Wilson-Poe A

Dow Neurobiology, Legacy Research Institute, Legacy Health, Portland, OR, USA.

5 preprints · 1 paper · ORCID

PreprintPsilocybin

Oregon’s State-Regulated Psilocybin Services: Early Real-World Safety Signals

Luoma JB, Chwyl C, Jarlais DD +6

Europe PMC2026
PreprintPsilocybin

Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs

Luoma JB, Hoffman K, Wilson-Poe A +12

Europe PMC2026
PreprintPsilocybin

Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives

Chwyl C, Bazinet A, Wilson-Poe A +5

Europe PMC2026
PreprintPsilocybin

Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives

Chwyl C, Bazinet A, Wilson-Poe A +5

Europe PMC2026
PreprintPsilocybin

Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts

Luoma JB, Wilson-Poe A, Pertl K +5

Europe PMC2024
ArticlePsilocybin

Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts.

Wilson-Poe A, Hoffman K, Pertl K +5

Europe PMC2025